Carasent ASA (CARA) - Total Assets

Latest as of March 2026: Skr921.88 Million SEK ≈ $99.21 Million USD

Based on the latest financial reports, Carasent ASA (CARA) holds total assets worth Skr921.88 Million SEK (≈ $99.21 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Carasent ASA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Carasent ASA - Total Assets Trend (2002–2025)

This chart illustrates how Carasent ASA's total assets have evolved over time, based on quarterly financial data. Check Carasent ASA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Carasent ASA - Asset Composition Analysis

Current Asset Composition (December 2025)

Carasent ASA's total assets of Skr921.88 Million consist of 23.1% current assets and 76.9% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr0.00 14.8%
Accounts Receivable Skr63.66 Million 6.8%
Inventory Skr0.00 0.0%
Property, Plant & Equipment Skr0.00 0.0%
Intangible Assets Skr204.02 Million 21.7%
Goodwill Skr486.85 Million 51.7%

Asset Composition Trend (2002–2025)

This chart illustrates how Carasent ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CARA market cap.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Carasent ASA's current assets represent 23.1% of total assets in 2025, a decrease from 71.5% in 2002.
  • Cash Position: Cash and equivalents constituted 14.8% of total assets in 2025, down from 62.4% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 72.0% of total assets, an increase from 10.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 51.7% of total assets.

Carasent ASA Competitors by Total Assets

Key competitors of Carasent ASA based on total assets are shown below.

Company Country Total Assets
INVENTURUS KNOWLEDGE SO L
NSE:IKS
India Rs36.06 Billion
Waystar Holding Corp. Common Stock
NASDAQ:WAY
USA $5.84 Billion
DocCheck AG
XETRA:AJ91
Germany €55.68 Million
Kovo Healthtech Corp
V:KOVO
Canada CA$6.64 Million
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
ARTRYA Ltd
AU:AYA
Australia AU$92.19 Million
Cogstate Ltd
AU:CGS
Australia AU$64.77 Million

Carasent ASA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.58 2.74 6.05
Quick Ratio 1.58 2.74 6.51
Cash Ratio 0.00 0.00 0.00
Working Capital Skr71.60 Million Skr197.95 Million Skr197.92 Million

Carasent ASA - Advanced Valuation Insights

This section examines the relationship between Carasent ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.10
Latest Market Cap to Assets Ratio 0.18
Asset Growth Rate (YoY) -12.2%
Total Assets Skr941.01 Million
Market Capitalization $165.12 Million USD

Valuation Analysis

Below Book Valuation: The market values Carasent ASA's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Carasent ASA's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Carasent ASA (2002–2025)

The table below shows the annual total assets of Carasent ASA from 2002 to 2025.

Year Total Assets Change
2025-12-31 Skr941.01 Million
≈ $101.27 Million
-12.24%
2024-12-31 Skr1.07 Billion
≈ $115.40 Million
-1.95%
2023-12-31 Skr1.09 Billion
≈ $117.69 Million
-20.22%
2022-12-31 Skr1.37 Billion
≈ $147.53 Million
+5.39%
2021-12-31 Skr1.30 Billion
≈ $139.99 Million
+157.61%
2020-12-31 Skr504.95 Million
≈ $54.34 Million
+269.49%
2019-12-31 Skr136.66 Million
≈ $14.71 Million
+14.61%
2018-12-31 Skr119.24 Million
≈ $12.83 Million
+93.03%
2017-12-31 Skr61.78 Million
≈ $6.65 Million
+22.89%
2016-12-31 Skr50.27 Million
≈ $5.41 Million
-76.90%
2015-12-31 Skr217.57 Million
≈ $23.41 Million
-4.66%
2014-12-31 Skr228.20 Million
≈ $24.56 Million
+1.73%
2013-12-31 Skr224.32 Million
≈ $24.14 Million
+5.52%
2012-12-31 Skr212.59 Million
≈ $22.88 Million
+6.21%
2011-12-31 Skr200.16 Million
≈ $21.54 Million
+1.96%
2010-12-31 Skr196.31 Million
≈ $21.13 Million
+1.07%
2009-12-31 Skr194.24 Million
≈ $20.90 Million
-20.75%
2008-12-31 Skr245.09 Million
≈ $26.38 Million
+10.65%
2007-12-31 Skr221.49 Million
≈ $23.84 Million
-19.69%
2006-12-31 Skr275.78 Million
≈ $29.68 Million
+95.21%
2005-12-31 Skr141.27 Million
≈ $15.20 Million
+117.52%
2004-12-31 Skr64.95 Million
≈ $6.99 Million
+32.88%
2003-12-31 Skr48.88 Million
≈ $5.26 Million
-19.43%
2002-12-31 Skr60.66 Million
≈ $6.53 Million
--

About Carasent ASA

ST:CARA Sweden Health Information Services
Market Cap
$165.12 Million
Skr1.53 Billion SEK
Market Cap Rank
#17370 Global
#293 in Sweden
Share Price
Skr22.95
Change (1 day)
-1.08%
52-Week Range
Skr22.00 - Skr30.55
All Time High
Skr30.55
About

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient comm… Read more